Yusaku Miyamae

Prof. Dr. Yusaku Miyamae

Faculty of Life and Environmental Sciences, University of Tsukuba, Ibaraki 305-8572, Japan
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2010 in Neuroscience
Verified
Journal Article
Open access
JHJ. Han
J. Han
Yusaku MiyamaeYusaku Miyamae
Yusaku Miyamae
HSHideyuki Shigemori
Hideyuki Shigemori
Hiroko IsodaHiroko Isoda
Hiroko Isoda
As aged population dramatically increases in these decades, efforts should be made on the intervention for curing age-associated neurologic degenerative diseases such as Alzheimer's disease (AD). Caffeoylquinic acid (CQA), an antioxidant component and its derivatives are natural functional compounds isolated from a variety of plants. In this study, we determined the neuroprotective effect of 3,5-di-O-CQA on Abeta(1-42) treated SH-SY5Y cells using MTT assay. To investigate the possible neuroprotective mechanism of 3,5-di-O-CQA, we performed proteomics analysis, real-time PCR analysis and measurement of the intracellular ATP level. In addition, we carried out the measurement of escape latency time to find the hidden platform in Morris water maze (MWM), real-time PCR using senescence-accelerated-prone mice (SAMP) 8 and senescence-accelerated-resistant mice (SAMR) 1 mice. Results showed that 3,5-di-O-CQA had neuroprotective effect on Abeta (1-42) treated cells. The mRNA expression of glycolytic enzyme (phosphoglycerate kinase-1; PGK1) and intracellular ATP level were increased in 3,5-di-O-CQA treated SH-SY5Y cells. We also found that 3,5-di-O-CQA administration induced the improvement of spatial learning and memory on SAMP8 mice, and the overexpression of PGK1 mRNA. These findings suggest that 3,5-di-O-CQA has a neuroprotective effect on neuron through the upregulation of PGK1 expression and ATP production activation.

1 October 2012 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
Yusaku MiyamaeYusaku Miyamae
Yusaku Miyamae
MKManami Kurisu
Manami Kurisu
KMKazuma Murakami
Kazuma Murakami
JHJunkyu Han
Junkyu Han
Hiroko IsodaHiroko Isoda
Hiroko Isoda
HSHideyuki Shigemori
Hideyuki Shigemori

1 January 2011 in Chemical and Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
Yusaku MiyamaeYusaku Miyamae
Yusaku Miyamae
MKManami Kurisu
Manami Kurisu
JHJunkyu Han
Junkyu Han
Hiroko IsodaHiroko Isoda
Hiroko Isoda
HSHideyuki Shigemori
Hideyuki Shigemori
Caffeoylquinic acid (CQA) is one of the phenylpropanoids which have various bioactivities such as antioxidant, antibacterial, anticancer, antihistamic, and other biological effects. We previously reported that 3,5-di-O-caffeoylquinic acid inhibited amyloid β1—42-induced cellular toxicity on human neuroblastoma SH-SY5Y cells and increased the mRNA expression level of glycolytic enzymes and the intracellular ATP level. To investigate structure–activity relationship on the accelerating activity on ATP production, we synthesized 1,4,5-tri-O-caffeoylquinic acid, 4,5-di-O-caffeoylquinic acid, 3,4,5-tri-O-caffeoylquinic acid, and other derivatives. Additionally, we evaluated intracellular ATP level in SH-SY5Y treated with each CQA derivative. As a result, 3,4,5-tri-O-caffeoylquinic acid showed the highest accelerating activity on ATP production among tested compounds. It was suggested that caffeoyl groups bound to quinic acid are important for activity and the more caffeoyl groups are bound to quinic acid, the higher accelerating activity on ATP production exhibits.

23 June 2013 in Bioscience, Biotechnology, and Biochemistry
Verified
Journal Article
Closed access
MKManami Kurisu
Manami Kurisu
Yusaku MiyamaeYusaku Miyamae
Yusaku Miyamae
KMKazuma Murakami
Kazuma Murakami
JHJunkyu Han
Junkyu Han
Hiroko IsodaHiroko Isoda
Hiroko Isoda
HSHideyuki Shigemori
Hideyuki Shigemori
We examined the effects of acteoside (1a), which was isolated from Orobanche minor, and its derivatives on the aggregation of a 42-mer amyloid β protein (Aβ42) in our search for anti-amyloidogenic compounds for Alzheimer's disease (AD) therapy. Acteoside (1a) strongly inhibited the aggregation of Aβ42 in a dose-dependent manner. The structure-activity relationship for acteoside (1a) and related compounds suggests the catechol moiety of phenylethanoid glycosides to be essential for this inhibitory activity.

5 October 2007 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
MKMitsuko Kawano
Mitsuko Kawano
KMKyoko Matsuyama
Kyoko Matsuyama
Yusaku MiyamaeYusaku Miyamae
Yusaku Miyamae
HSHiroshi Shinmoto
Hiroshi Shinmoto
MKMohamed Elyes Kchouk
Mohamed Elyes Kchouk
Hiroko IsodaHiroko Isoda
Hiroko Isoda

12 October 2015 in ACS Chemical Biology
Verified
Journal Article
Closed access
AOAnna Ohtera
Anna Ohtera
Yusaku MiyamaeYusaku Miyamae
Yusaku Miyamae
KYKotaro Yoshida
Kotaro Yoshida
KMKazuhiro Maejima
Kazuhiro Maejima
TAToru Akita
Toru Akita
MNMasaya Nagao
Masaya Nagao